Skip to content

Author

Shreya Srivastava

We have 2 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

From Crisis to Clarity: The Essential Role of Genetic Counseling and Emerging Risk-Reducing Strategies in BRCA1 -Associated Breast Cancer – A Case Report

Abstract Women with BRCA1 pathogenic variants face high lifetime risks of breast and ovarian cancer, requiring complex risk-reducing decisions. We report a 35-year-old woman with node-negative triple-negative breast cancer who achieved a pathologic complete response after neoadjuvant chemotherapy and breast-conserving...

Archi Rungta, Anjana Anoop, Srushti Uthale et al. · 0 citations
Review Aug 2026

KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms

KRAS-mutant NSCLC is transitioning from historically untargetable disease to a therapeutically actionable subset, and future progress hinges on resistance-directed combinations, biomarker-guided personalization, expansion to non-G12C mutants, and evaluation in earlier disease settings.

A. Kapoor, Bipinesh Sansar, Anuj Gupta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.